Bioanalytical outsourcing strategy in China-Reference-Cited by-同舟云学术

Bioanalytical outsourcing strategy in China

Published:2017-08 Issue:15 Volume:9 Page:1157-1159
ISSN:1757-6180
Container-title:Bioanalysis
language:en
Short-container-title:Bioanalysis

Author:

Dong Kelly¹,Tang Daniel²

Affiliation:

1. GlaxoSmithKline R&D China, Shanghai, China

2. United-Power PharmaTech, Beijing, China

Publisher

Future Science Ltd

Subject

Medical Laboratory Technology,Clinical Biochemistry,General Pharmacology, Toxicology and Pharmaceutics,General Medicine,Analytical Chemistry

Link

http://www.future-science.com/doi/pdf/10.4155/bio-2017-4988

Reference4 articles.

1. Integrating internal and external bioanalytical support to deliver a diversified pharmaceutical portfolio

2. Zhong D, Dong K, Wei M, Li J, Tang D. Update on Chinese Regulated Bioanalysis. Bioanalysis Zone (2016). www.bioanalysis-zone.com/2016/02/07/update-on-chinese-regulated-bioanalysis/.

3. An interlaboratory transfer of a multi-analyte assay between continents

4. Chinese Pharmacopoeia. The Guideline for Method Validation of Quantitative Analysis of Biological Samples (2015).www.edqm.eu/sites/default/files/1710_1130_brief_introduction_of_chinese_pharmacopoeia_2015_vol._iv-en.pdf.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficient interactions with bioanalytical contract research organizations: inside scoop;Bioanalysis;2022-08

2. Innovation Dynamics and Globalization Trends of High-Throughput Bioanalytical Methods from a Literature Survey;Bioanalysis;2020-06

3. New development of the Chinese bioanalytical landscape and update of the China Bioanalysis Forum (CBF);Bioanalysis;2019-04